Danno Daisuke1, Shiho Suzuki2, Tsubasa Takizawa3, Ryotaro Ishii4, Masayuki Hamakawa5, Yoshinori Tanizawa6, Minako Sato6, Satoshi Osaga6, Mika Komori6 (1.Tominaga Hospital, Osaka, Japan, 2.Dokkyo Medical University, Mibu, Japan, 3.Keio University School of Medicine, Tokyo, Japan, 4.Kyoto Prefectural University of Medicine, Kyoto, Japan, 5.Social Survey Research Information Co., Ltd, Tokyo, Japan, 6.Eli Lilly Japan K.K., Kobe, Japan)
Session information
Late Breaking Symposium
English
[LB] Late Breaking Symposium
Thu. May 30, 2024 3:30 PM - 5:30 PM Room8 (Hall D1, D Block, 1F, TIF)
Chair:Akatsuki Kubota (Department of Neurology, The University of Tokyo, Japan)
Hiroya Kuwahara (Department of Neurology and Neurological Science, Graduate School, Tokyo Medical and Dental University, Japan)
Masahiko Hara1,2, Yuichiro Murakawa2, Keito Shinmoto2 (1.Centre for Community-Based Healthcare Research and Education, Shimane University Faculty of Medicine, Japan, 2.Department of Neurology and Clinical Rehabilitation, mediVR Rehabilitation Center, Japan)
Cancelled
Hiroya Naruse1,2, Hiroyuki Ishiura1,3, Kayoko Esaki4, Jun Mitsui1,2, Wataru Satake1, Yuka Machino5, Yasumasa Kokubo6, Hirotoshi Hamaguchi7, Takeo Yoshikawa8, Shoji Tsuji9, Tatsushi Toda1 (1.Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan, 2.Department of Precision Medicine Neurology, Graduate School of Medicine, The University of Tokyo, Japan, 3.Department of Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan, 4.Department of Biotechnology and Life Sciences, Faculty of Biotechnology and Life Sciences, Sojo University, Japan, 5.Department of Neurology, National Hospital Organization Mie National Hospital, Japan, 6.Kii ALS/PDC Research Center, Graduate School of Regional Innovation Studies, Mie University, Japan, 7.Department of Neurology, Kita-Harima Medical Center, Japan, 8.Laboratory of Molecular Psychiatry, RIKEN Center for Brain Science, Japan, 9.Institute of Medical Genomics, International University of Health and Welfare, Japan)
Tatsuhiko Sano1,2, Tetsuya Nagata1,2,3, Satoe Ebihara1,2, Kie Yoshida-Tanaka1,2, Ayako Nakamura1,2, Asuka Sasaki1,2, Aki Shimozawa5, Hideki Mochizuki4, Toshiki Uchihara1,2, Masato Hasegawa5, Takanori Yokota1,2,3 (1.Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan, 2.Center for Brain Integration Research, Tokyo Medical and Dental University, Japan, 3.NucleoTIDE and PepTIDE Drug Discovery Center, Tokyo Medical and Dental University, Japan, 4.Department of Neurology, Osaka University Graduate School of Medicine, Japan, 5.Department of Brain and Neurosciences, Tokyo Metropolitan Institute of Medical Science, Japan)
Kazunori Toyoda1, Yasuyuki Iguchi2, Ichiro Nakahara3, Hirofumi Tomita4, Teruyuki Hirano5, Masahiro Yasaka6, Erika Pouliot7, Franco Noreli7, Kazuhiro Hidaka8, Ken Okumura9 (1.Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan, 2.Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan, 3.Department of Neurosurgery, Fujita Health University Bantane Hospital, Nagoya, Japan, 4.Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan, 5.Department of Stroke and Cerebrovascular Medicine, Kyorin University School of Medicine, Tokyo, Japan, 6.Department of Cerebrovascular Medicine, Fukuoka Neurosurgical Hospital, Fukuoka, Japan, 7.Cardiac Rhythm Management, Clinical Department, Medtronic Inc., Minneapolis, USA, 8.Japan Clinical and Medical Affairs, Medtronic Japan Co., Ltd., Tokyo, Japan, 9.Division of Cardiology, Saiseikai Kumamoto Hospital, Kumamoto, Japan)
Hideki Shimazu1,4, Shinichi Matsumoto2, Hidetaka Koizumi3, Satoshi Goto5,6, Masatoshi Koga5, Ryo Itabashi6, Yusuke Yakushiji7, on behalf of the ACUTE-PRAS Investigators (1.Department of Pharmacology, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women’s University, Japan, 2.Department of Neurology, Osaka Neurological Institute, Japan, 3.Department of Neurology, Kyoto Prefectural Rehabilitation Hospital for the Disabled, Japan, 4.Department of Neurology, Itsuki Hospital, Japan, 5.Department of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University, Japan, 6.Center for Drug Discovery and Development Sciences, Research Organization of Science and Technology, Ritsumeikan University, Japan, 7.Department of Neurology, Kansai Medical University, Japan)
Shigeru Fujimoto1, Kazumi Kimura2, Yasuyuki Iguchi3, Hiroshi Yamagami4 (1.Department of Medicine, Division of Neurology, Jichi Medical University, Japan, 2.Department of Neurology, Graduate School of Medicine, Nippon Medical School, Japan, 3.Department of Neurology, The Jikei University School of Medicine, Japan, 4.Department of Stroke Neurology, National Hospital Organization Osaka National Hospital, Japan, 5.Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Japan, 6.Stroke Center, Division of Neurology and Gerontology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Japan, 7.Department of Neurology, Kansai Medical University, Japan)
Gaurav Chopra1,3, Priya Prakash1, Palak Manchanda1, Evi Paouri2, Kanchan Bisht1, Kaushik Sharma1, Ahad Hossain1, Prageeth R. Wijewardhane1, Caitlin E. Randolph1, Alexis Crockett2, Nadia Gasmi2, Jonathan Fine1, Victoria Wendt1, Krupal P. Jethava1, Matthew G. Clark1, Sarah Stanko2, Elizabeth A. Thayer1, Anxhela Gjojdeshi2, Ryann Davis1, Dhruv Hardikar1, Chi Zhang1, Dimitrios Davalos2 (1.Department of Chemistry, Purdue University, USA, 2.Department of Neurosciences, Cleveland Clinic, USA, 3.Purdue Institute for Integrative Neuroscience, Regenstrief Center for Healthcare Engineering, Purdue University, Purdue Institute for Drug Discovery, Purdue University, USA)
Saraswati Nashi1, Tanushree Chawla1, Dipti Baskar1, Kiran Polavarapu2, Seena Vengalil1, Mainak Bardhan1, Veeramani Preethish-Kumar1, Ramya Sukrutha3, Gopikrishnan Unnikrishnan1, Akshata Huddar1, Hansashree Padmanabha1, Ram Murthy Anjanappa3, Nandeesh Bevinahalli4, Vidya Nittur1, Manoj Rajanna1, Gautham Arunachal Udupi3, Atchayaram Nalini1 (1.Department of Neurology, Neuroscience Faculty Center, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, 560029, India, 2.Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Canada, 3.Department of Human Genetics, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, 560029, India, 4.Department of Neuropathology, National Institute of Mental Health and Neurosciences, Bengaluru, 560029, India)